Eugia Steriles receives EIR from US FDA
The inspection was conducted between March 28, 2024 to April 05, 2024
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Eugia Pharma Specialities
Eugia Pharma gets USFDA nod for posaconazole injection, 300 mg/16.7 mL, single-dose vial
The approved product has an estimated market size of $25.4 million for the twelve months ending October 2023, according to IQVIA
Eugia Pharma receives US FDA nod for Amphotericin B Liposome Injection
Has an estimated market size of around US$ 145 million for the 12 months ending September 2022, according to IQVIA.
Aurobindo Pharma acquires 100 per cent share of Eugia Pharma Specialities
The cost of acquisition is Rs 274.22 crores for a total of 15,02,49,382 equity shares